BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8897161)

  • 1. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
    Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
    J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.
    Ichimura H; Tamura I; Kurimura O; Koda T; Mizui M; Tsuchie H; Kurimura T
    J Med Virol; 1994 Jul; 43(3):212-5. PubMed ID: 7523579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HCV RIBA/LiaTek reactivity and HCV genotype in EIA-negative patients with viremia.
    Brojer E; Kryczka W; Medyńska J; Grabarczyk P; Kubicka J; Głoskowska-Moraczewska Z; Loch T; Cianciara J; Juszczyk J; Bolewska B; Zupańska B
    J Med Virol; 1999 Dec; 59(4):451-5. PubMed ID: 10534725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group.
    Andreu J; Abad MA; Sanchez-Quijano A; Torronteras R; Luque F; Garcia de las Heras J; Soto B; Pineda JA; Leal M; Lissen E
    J Intern Med; 1994 Jul; 236(1):73-7. PubMed ID: 7517430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.
    Lavanchy D; Mayerat C; Morel B; Schneider P; Zufferey C; Gonvers JJ; Pécoud A; Frei PC
    J Clin Microbiol; 1994 Sep; 32(9):2272-5. PubMed ID: 7529253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
    Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
    J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.
    Darwish MA; Raouf TA; Rushdy P; Constantine NT; Rao MR; Edelman R
    Am J Trop Med Hyg; 1993 Oct; 49(4):440-7. PubMed ID: 7692754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.